Literature DB >> 30416278

External Cephalic Version: A Dying Art Worth Reviving.

Raj Lakshmi Nalam1, Priya Chinnachamy2, Paul Emmanuel2.   

Abstract

PURPOSE: Breech presentation is the most common abnormal presentation occurring in 3-4% of all deliveries. Incidence of caesarean section for breech presentation has increased markedly in the last few decades. Attempting external cephalic version (ECV) reduces the chance of non-cephalic presentation at term, thus reducing the rate of caesarean sections.
METHODS: Prospective study was conducted in secondary healthcare centre, in rural set-up from August 2013 to August 2015. A total of 52 patients were enrolled into the study.
RESULTS: ECV was successful in 32 out of 52 patients with overall success of 61.5%. Out of the 32 successful ECVs, 24 patients delivered vaginally (75%) (p value 0.00), 6 patients delivered by caesarean section, and 2 patients were lost to follow-up. Transverse lie had 100% success rate for ECV (p value 0.005). Gravidity, placental position, gestational age and use of tocolytics did not influence the success rate of ECV. Most common problem observed during the procedure was abdominal discomfort.
CONCLUSION: ECV is a safe procedure with high percentage of patients delivering vaginally after successful version. Hence, acquiring skills in ECV should be considered mandatory in the postgraduate training of future obstetricians.

Entities:  

Keywords:  Breech presentation; External cephalic version (ECV); Transverse lie

Year:  2018        PMID: 30416278      PMCID: PMC6207544          DOI: 10.1007/s13224-018-1090-z

Source DB:  PubMed          Journal:  J Obstet Gynaecol India        ISSN: 0975-6434


  10 in total

1.  Single-institute experience, management, success rate, and outcome after external cephalic version at term.

Authors:  Gerhard Bogner; Fang Xu; Christian Simbrunner; Alfred Bacherer; Klaus Reisenberger
Journal:  Int J Gynaecol Obstet       Date:  2011-12-09       Impact factor: 3.561

Review 2.  Effectiveness of nifedipine tocolysis to facilitate external cephalic version: a systematic review.

Authors:  C B Wilcox; N Nassar; C L Roberts
Journal:  BJOG       Date:  2010-12-24       Impact factor: 6.531

3.  The complications of external cephalic version: results from 805 consecutive attempts.

Authors:  S Collins; P Ellaway; D Harrington; M Pandit; L W M Impey
Journal:  BJOG       Date:  2007-03-12       Impact factor: 6.531

Review 4.  Ultrasound factors to predict the outcome of external cephalic version: a meta-analysis.

Authors:  M Kok; J Cnossen; L Gravendeel; J A Van Der Post; B W Mol
Journal:  Ultrasound Obstet Gynecol       Date:  2009-01       Impact factor: 7.299

5.  External cephalic version of non-cephalic presentation; is it worthwhile?

Authors:  Tomas Gottvall; Charlotte Ginstman
Journal:  Acta Obstet Gynecol Scand       Date:  2011-07-27       Impact factor: 3.636

Review 6.  External cephalic version for breech presentation at term.

Authors:  G Justus Hofmeyr; Regina Kulier
Journal:  Cochrane Database Syst Rev       Date:  2012-10-17

7.  Predictors of successful external cephalic version in an Australian maternity hospital.

Authors:  Alex Mowat; Glenn Gardener
Journal:  Aust N Z J Obstet Gynaecol       Date:  2013-12-23       Impact factor: 2.100

8.  Planned caesarean section versus planned vaginal birth for breech presentation at term: a randomised multicentre trial. Term Breech Trial Collaborative Group.

Authors:  M E Hannah; W J Hannah; S A Hewson; E D Hodnett; S Saigal; A R Willan
Journal:  Lancet       Date:  2000-10-21       Impact factor: 79.321

9.  Predictors of successful external cephalic version and assessment of success for vaginal delivery.

Authors:  Liat Salzer; Ran Nagar; Nir Melamed; Arnon Wiznitzer; Yoav Peled; Yariv Yogev
Journal:  J Matern Fetal Neonatal Med       Date:  2014-04-09

10.  Consequences of a primary elective cesarean delivery across the reproductive life.

Authors:  Emily S Miller; Katherine Hahn; William A Grobman
Journal:  Obstet Gynecol       Date:  2013-04       Impact factor: 7.661

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.